Choong CJ, Sasaki T, Hayakawa H, Yasuda T, Baba K, Hirata Y, Uesato S and Hideki Mochizuki. A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease. Neurobiology of aging Neurobiol Aging. 37,103-16,2016.1
Beck G, Shinzawa K, Hayakawa H, Baba K, Sumi-Akamaru H, Tsujimoto Y, Mochizuki H. Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A2β Knockout Mice. PLoS One. 14,11(4):e0153789,2016.4
Uehara T, Beck G, Baba K, Mihara M, Okuno T, Sumi H, Nakatsuji Y, Mochizuki H. Tumefactive brain lesion with rapid cavity formation associated with anti-aquaporin-4 antibody.Neurol Neuroimmunol Neuroinflamm.3(3), e230. 2016.4
漢方
Nakanishi M, Aya Nakae, Kishida Y, Baba K, Noriko Sakashita, Masahiko Shibata, Hideki Yoshikawa, Hagihara K. Go-sha-jinki-Gan (GJG) ameliorates allodynia in chronic constriction injury model mice via suppression of TNF-α expression in the spinal cord. Molecular Pain.12,1-16,2016.6
Choong CJ, Sasaki T, Hayakawa H, Yasuda T, Baba K, Hirata Y, Uesato S, and Mochizuki H. A Novel HDAC1/2 isoform-specific inhibitor K560 ameliorates MPP+/MPTP-mediated experimental Parkinson’s disease. 5th Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress (AOPMC). Manila, Philippines. 2016.3
Choong CJ, Sasaki T, Hayakawa H, Yasuda T, Baba K, Hirata Y, Uesato S, and Mochizuki H. HDAC1/2 isoform specific inhibitor for suppression of PD progression、第57回日本神経学会学術大会、神戸、2016.5
Hayakawa H, Baba K, Choong CJ, Araki K, Mochizuki H. Establishment of in vitro model to elucidate mechanism underlying propagation of α- synuclein、第57回日本神経学会学術大会、神戸、2016.5
Nakanishi M, Nakae A, Kishida Y, Sakashita N, Baba K, Shiomoto C, Shibata M, Yoshikawa H, Hagihara K:Goshajinki-Gan (GJG) attenuated allodynia via suppression of the TNF-α derived from microglia in chronic constriction injury model. 16th World Congress on Pain (IASP 2016) in Yokohama, Japan, 2016.10